Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CSL Nabs First ‘Direct Access’ Funding Agreement In France For Its Gene Therapy

Dec 15 2023

• By Eliza Slawther

3d rendered medical illustration of a sickle cell — • Source: Shutterstock

Related Content

England: CSL Undeterred By Draft NICE Rejection Of Its £2.6m Hemophilia B Gene Therapy

Aug 02 2023

CSL/UniQure’s Hemgenix To Enter Uncertain EU Market After Regulatory Nod

Feb 21 2023

Hemophilia B Gene Therapy Among Five Drugs On Track For EU-Wide Approval

Dec 16 2022

Access To Innovation Looking Brighter In France

Jul 28 2022

Additional Topics

Europe EU France Health Technology Assessment Gene Therapy Market Access Rare Diseases Regenerative Medicine Reimbursement BioPharmaceutical Blood & Coagulation Disorders

More from Health Technology Assessment

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window